Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Grindey

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|November 8, 1996
Dietary folate and folylpolyglutamate synthetase activity in normal and neoplastic murine tissues and human tumor xenograftsS B Gates, J F Worzalla, C Shih, et al.
Cancer Research|March 1, 1980
Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesisJ J Kinahan, Z P Pavelic, R J Leonard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Evaluation of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcomaP J Houghton, J A Houghton, L Myers, et al.
Cancer Research|February 1, 1992
Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiationV Heinemann, Y Z Xu, S Chubb, et al.
Molecular Pharmacology|October 1, 1990
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidineV Heinemann, Y Z Xu, S Chubb, et al.
Anti-Cancer Drugs|April 1, 1995
Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenograftsP J Houghton, P J Cheshire, L Myers, et al.
Cancer Research|May 15, 1996
Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acidT Alati, J F Worzalla, C Shih, et al.
Anti-Cancer Drugs|April 1, 1992
Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming unitsA R Hanauske, D Degen, M H Marshall, et al.
Biochemical Pharmacology|April 1, 1990
Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-ureaP J Houghton, F C Bailey, G S Germain, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analoguesG Powis, A Gallegos, R T Abraham, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|November 8, 1996
Dietary folate and folylpolyglutamate synthetase activity in normal and neoplastic murine tissues and human tumor xenograftsS B Gates, J F Worzalla, C Shih, et al.
Cancer Research|March 1, 1980
Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesisJ J Kinahan, Z P Pavelic, R J Leonard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Evaluation of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcomaP J Houghton, J A Houghton, L Myers, et al.
Cancer Research|February 1, 1992
Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiationV Heinemann, Y Z Xu, S Chubb, et al.
Molecular Pharmacology|October 1, 1990
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidineV Heinemann, Y Z Xu, S Chubb, et al.
Anti-Cancer Drugs|April 1, 1995
Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenograftsP J Houghton, P J Cheshire, L Myers, et al.
Cancer Research|May 15, 1996
Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acidT Alati, J F Worzalla, C Shih, et al.
Anti-Cancer Drugs|April 1, 1992
Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming unitsA R Hanauske, D Degen, M H Marshall, et al.
Biochemical Pharmacology|April 1, 1990
Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-ureaP J Houghton, F C Bailey, G S Germain, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analoguesG Powis, A Gallegos, R T Abraham, et al.
Pageof 6